Chr Hansen has secured a €75m loan from the European Investment Bank (EIB) to support its microbial solutions work as the bioscience company ramps up its R&D spend.
Chr Hansen wins €75m to 'develop new microbial solutions'
jeudi 17 décembre 2015
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire